BR0213937A - Matriz sintética para encravamento celular controlado e regeneração de tecido - Google Patents
Matriz sintética para encravamento celular controlado e regeneração de tecidoInfo
- Publication number
- BR0213937A BR0213937A BR0213937-5A BR0213937A BR0213937A BR 0213937 A BR0213937 A BR 0213937A BR 0213937 A BR0213937 A BR 0213937A BR 0213937 A BR0213937 A BR 0213937A
- Authority
- BR
- Brazil
- Prior art keywords
- precursor molecule
- molecular weight
- tissue regeneration
- precursor
- synthetic matrix
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
- C08L71/02—Polyalkylene oxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6903—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being semi-solid, e.g. an ointment, a gel, a hydrogel or a solidifying gel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/26—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/041—Mixtures of macromolecular compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
- C08G65/332—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof
- C08G65/3322—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof acyclic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/334—Polymers modified by chemical after-treatment with organic compounds containing sulfur
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2203/00—Applications
- C08L2203/02—Applications for biomedical use
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Vascular Medicine (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Dispersion Chemistry (AREA)
- Composite Materials (AREA)
- Materials Engineering (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
- Medicinal Preparation (AREA)
Abstract
"MATRIZ SINTéTICA PARA ENCRAVAMENTO CELULAR CONTROLADO E REGENERAçãO DE TECIDO". A presente invenção refere-se a biomaterial compreendendo uma rede polimérica tridimensional obtenível da reação de pelo menos uma primeira e uma segunda molécula precursora. A primeira molécula precursora é pelo menos um componente ramificado trifuncional compreendendo pelo menos três ramificações substancialmente similares em peso molecular e a segunda molécula precursora é pelo menos um componente bifuncional. A relação de peso equivalente dos grupos funcionais das primeira e a segunda molécula precursora está em uma faixa entre 0,9 e 1,1. O peso molecular das ramificações da primeira molécula precursora, o peso molecular da segunda molécula precursora e a funcionalidade dos pontos de ramificação são selecionados tal que o conteúdo de água das redes poliméricas é entre 0% em peso de equilíbrio e 92% em peso do peso total da rede polimérica após a conclusão de captação de água. A presente invenção ensina um modo para melhorar as características de matrizes sintéticas que são úteis para aplicações de cicatrização de ferimento.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33778301P | 2001-11-07 | 2001-11-07 | |
PCT/EP2002/012458 WO2003040235A1 (en) | 2001-11-07 | 2002-11-07 | Synthetic matrix for controlled cell ingrowth and tissue regeneration |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0213937A true BR0213937A (pt) | 2004-10-26 |
Family
ID=23321985
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0213937-5A BR0213937A (pt) | 2001-11-07 | 2002-11-07 | Matriz sintética para encravamento celular controlado e regeneração de tecido |
Country Status (11)
Country | Link |
---|---|
US (1) | US20050065281A1 (pt) |
EP (1) | EP1446453A1 (pt) |
JP (1) | JP2005508237A (pt) |
KR (1) | KR101054023B1 (pt) |
CN (1) | CN1328319C (pt) |
AU (1) | AU2002363343B2 (pt) |
BR (1) | BR0213937A (pt) |
CA (1) | CA2466116C (pt) |
HK (1) | HK1080500B (pt) |
NO (1) | NO20042357L (pt) |
WO (1) | WO2003040235A1 (pt) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7601685B2 (en) | 1998-08-27 | 2009-10-13 | Eidgenossische Technische Hochschule Zurich | Growth factor modified protein matrices for tissue engineering |
US6958212B1 (en) | 1999-02-01 | 2005-10-25 | Eidgenossische Technische Hochschule Zurich | Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
US7744912B1 (en) | 1999-02-01 | 2010-06-29 | Eidgenossische Technische Hochschule Zurich | Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups |
US7291673B2 (en) | 2000-06-02 | 2007-11-06 | Eidgenossiche Technische Hochschule Zurich | Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
US6702744B2 (en) * | 2001-06-20 | 2004-03-09 | Advanced Cardiovascular Systems, Inc. | Agents that stimulate therapeutic angiogenesis and techniques and devices that enable their delivery |
US8608661B1 (en) | 2001-11-30 | 2013-12-17 | Advanced Cardiovascular Systems, Inc. | Method for intravascular delivery of a treatment agent beyond a blood vessel wall |
US7247609B2 (en) | 2001-12-18 | 2007-07-24 | Universitat Zurich | Growth factor modified protein matrices for tissue engineering |
EP1864681A1 (en) | 2001-12-18 | 2007-12-12 | Eidgenössische Technische Hochschule Zürich | Growth factor modified protein matrices for tissue engineering |
EP1465989B1 (en) * | 2001-12-18 | 2008-02-20 | Eidgenossisch Technische Hochschule Zurich | Growth factor modified protein matrices for tissue engineering |
US8282912B2 (en) | 2002-03-22 | 2012-10-09 | Kuros Biosurgery, AG | Compositions for tissue augmentation |
US7361368B2 (en) * | 2002-06-28 | 2008-04-22 | Advanced Cardiovascular Systems, Inc. | Device and method for combining a treatment agent and a gel |
US7641643B2 (en) * | 2003-04-15 | 2010-01-05 | Abbott Cardiovascular Systems Inc. | Methods and compositions to treat myocardial conditions |
US8821473B2 (en) | 2003-04-15 | 2014-09-02 | Abbott Cardiovascular Systems Inc. | Methods and compositions to treat myocardial conditions |
ATE385423T1 (de) | 2004-06-16 | 2008-02-15 | Straumann Holding Ag | Abdeckmembran |
US7282584B2 (en) | 2004-06-16 | 2007-10-16 | Straumann Holding Ag | Methylene blue |
CA2589095C (en) * | 2004-12-10 | 2012-05-08 | Straumann Holding Ag | Protein formulation for administering an active enamel substance |
MX2007008319A (es) * | 2005-01-06 | 2007-10-04 | Kuros Biosurgery Ag | Matrices suplementadas para la reparacion de fracturas oseas. |
US8575101B2 (en) | 2005-01-06 | 2013-11-05 | Kuros Biosurgery Ag | Supplemented matrices for the repair of bone fractures |
WO2006073711A2 (en) | 2005-01-06 | 2006-07-13 | Kuros Biosurgery Ag | Use of a matrix comprising a contrast agent in soft tissues |
US8303972B2 (en) * | 2005-04-19 | 2012-11-06 | Advanced Cardiovascular Systems, Inc. | Hydrogel bioscaffoldings and biomedical device coatings |
US9539410B2 (en) | 2005-04-19 | 2017-01-10 | Abbott Cardiovascular Systems Inc. | Methods and compositions for treating post-cardial infarction damage |
US20080125745A1 (en) | 2005-04-19 | 2008-05-29 | Shubhayu Basu | Methods and compositions for treating post-cardial infarction damage |
US8828433B2 (en) * | 2005-04-19 | 2014-09-09 | Advanced Cardiovascular Systems, Inc. | Hydrogel bioscaffoldings and biomedical device coatings |
US8187621B2 (en) | 2005-04-19 | 2012-05-29 | Advanced Cardiovascular Systems, Inc. | Methods and compositions for treating post-myocardial infarction damage |
ES2385895T3 (es) * | 2006-02-20 | 2012-08-02 | Straumann Holding Ag | Material en gránulos y matriz |
US7732190B2 (en) * | 2006-07-31 | 2010-06-08 | Advanced Cardiovascular Systems, Inc. | Modified two-component gelation systems, methods of use and methods of manufacture |
US9242005B1 (en) | 2006-08-21 | 2016-01-26 | Abbott Cardiovascular Systems Inc. | Pro-healing agent formulation compositions, methods and treatments |
US9005672B2 (en) * | 2006-11-17 | 2015-04-14 | Abbott Cardiovascular Systems Inc. | Methods of modifying myocardial infarction expansion |
US8741326B2 (en) | 2006-11-17 | 2014-06-03 | Abbott Cardiovascular Systems Inc. | Modified two-component gelation systems, methods of use and methods of manufacture |
US8192760B2 (en) * | 2006-12-04 | 2012-06-05 | Abbott Cardiovascular Systems Inc. | Methods and compositions for treating tissue using silk proteins |
BRPI0810530B8 (pt) | 2007-04-13 | 2021-06-22 | Kuros Biosurgery Ag | composição, uso da mesma, biomaterial sintético, seu método de fabricação e kit para formar o mesmo |
EP2014256A1 (en) * | 2007-07-12 | 2009-01-14 | Straumann Holding AG | Composite bone repair material |
EP2203296A1 (fr) * | 2007-09-24 | 2010-07-07 | Berner Fachhochschule Für Technik Und Informatik HTI | Dispositif pour le dépôt de couches |
US8481067B2 (en) * | 2009-06-04 | 2013-07-09 | Clemson University Research Foundation | Methods for promoting the revascularization and reenervation of CNS lesions |
US8680182B2 (en) | 2009-06-04 | 2014-03-25 | Clemson University Research Foundation | Methods for promoting the revascularization and reenervation of CNS lesions |
US8609409B2 (en) | 2009-06-04 | 2013-12-17 | Clemson University | Methods and compositions for cell culture platform |
EP2380920A1 (en) * | 2010-04-22 | 2011-10-26 | QGel SA | Hydrogel precursor formulation and production process thereof |
WO2012106658A1 (en) | 2011-02-03 | 2012-08-09 | Northeastern University | Methods and compositions for highly specific capture and release of biological materials |
EP2686027B1 (en) | 2011-03-16 | 2021-05-05 | Kuros Biosurgery AG | Pharmaceutical formulation for use in spinal fusion |
WO2013120217A1 (en) * | 2012-02-14 | 2013-08-22 | Straumann Holding Ag | Bone repair material |
US20150032221A1 (en) * | 2012-02-14 | 2015-01-29 | Straumann Holding Ag | Bone repair material |
WO2015148512A1 (en) | 2014-03-24 | 2015-10-01 | Qt Holdings Corp | Shaped articles including hydrogels and methods of manufacture and use thereof |
WO2017036533A1 (en) | 2015-09-03 | 2017-03-09 | Ecole Polytechnique Federale De Lausanne (Epfl) | Three-dimensional hydrogels for culturing adult epithelial stem cells and organoids |
WO2017042301A1 (en) * | 2015-09-09 | 2017-03-16 | ETH Zürich | Injectable macroporous hydrogels |
US9790467B2 (en) | 2015-09-22 | 2017-10-17 | Qt Holdings Corp | Methods and compositions for activation or expansion of T lymphocytes |
KR101910807B1 (ko) * | 2016-10-31 | 2018-10-23 | 주식회사 세바바이오텍 | Peg-기반 하이드로젤을 포함하는 3차원 세포배양 시스템 |
EP3536353A1 (en) * | 2018-03-09 | 2019-09-11 | Kuros Biosurgery AG | Method and kits for producing a fibrin matrix |
EP3789049A1 (en) * | 2019-09-06 | 2021-03-10 | QGel SA | Method for obtaining healthy intestinal organoids |
EP4208534A1 (en) * | 2020-09-01 | 2023-07-12 | Katholieke Universiteit Leuven | Hydrogels for cell culture |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2373200T3 (es) * | 1995-12-18 | 2012-02-01 | Angiodevice International Gmbh | Composiciones de pol�?meros reticulados y métodos para su uso. |
US7744912B1 (en) * | 1999-02-01 | 2010-06-29 | Eidgenossische Technische Hochschule Zurich | Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups |
WO2001016210A1 (en) * | 1999-08-27 | 2001-03-08 | Cohesion Technologies, Inc. | Compositions that form interpenetrating polymer networks for use as high strength medical sealants |
JP2003535066A (ja) * | 2000-06-02 | 2003-11-25 | エイドジェノシスク テクニスク ホクシューレ チューリッヒ | 薬学的活性化合物の制御された送達のための共役付加反応 |
-
2002
- 2002-11-07 EP EP02790343A patent/EP1446453A1/en not_active Withdrawn
- 2002-11-07 KR KR1020047006993A patent/KR101054023B1/ko not_active IP Right Cessation
- 2002-11-07 BR BR0213937-5A patent/BR0213937A/pt active Search and Examination
- 2002-11-07 US US10/494,905 patent/US20050065281A1/en not_active Abandoned
- 2002-11-07 CN CNB028268814A patent/CN1328319C/zh not_active Expired - Lifetime
- 2002-11-07 AU AU2002363343A patent/AU2002363343B2/en not_active Expired
- 2002-11-07 JP JP2003542277A patent/JP2005508237A/ja active Pending
- 2002-11-07 WO PCT/EP2002/012458 patent/WO2003040235A1/en active Application Filing
- 2002-11-07 CA CA2466116A patent/CA2466116C/en not_active Expired - Lifetime
-
2004
- 2004-06-07 NO NO20042357A patent/NO20042357L/no not_active Application Discontinuation
-
2006
- 2006-01-05 HK HK06100209.1A patent/HK1080500B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU2002363343B2 (en) | 2008-07-24 |
CA2466116C (en) | 2012-04-24 |
KR20040062958A (ko) | 2004-07-09 |
CA2466116A1 (en) | 2003-05-15 |
WO2003040235A1 (en) | 2003-05-15 |
US20050065281A1 (en) | 2005-03-24 |
CN1668697A (zh) | 2005-09-14 |
NO20042357L (no) | 2004-07-13 |
HK1080500A1 (en) | 2006-04-28 |
HK1080500B (zh) | 2008-01-18 |
EP1446453A1 (en) | 2004-08-18 |
JP2005508237A (ja) | 2005-03-31 |
CN1328319C (zh) | 2007-07-25 |
KR101054023B1 (ko) | 2011-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0213937A (pt) | Matriz sintética para encravamento celular controlado e regeneração de tecido | |
ES2161444T3 (es) | Poliolefinas con reologia modificada. | |
RU2000128888A (ru) | Косметическая композиция, содержащая полимер с особыми свойствами и загущающий полимер | |
DE60138362D1 (de) | Bioadhäsive zusammensetzung | |
Kweon et al. | Preparation of semi‐interpenetrating polymer networks composed of silk fibroin and poly (ethylene glycol) macromer | |
ES2131266T3 (es) | Copolimeros de bloques lineales, procedimiento para su preparacion y composiciones adhesivas que los contienen. | |
ATE107335T1 (de) | Verfahren zur herstellung von membranen aus kollagen für medizinische anwendungen. | |
BR9910826A (pt) | Composição de modelagem para xampu | |
DE69728678D1 (de) | Hydrokolloid-wundgel | |
BRPI0413086A (pt) | matriz complexa, utilização da mesma, e processo de preparação de uma matriz biocompatìvel pouco biodegradável | |
BR0007296A (pt) | Novas formulações poliméricas contendo compostos perfluorados para a engenharia de células e tecidos para transplantes que melhoram o metabolismo e a sobrevivência celular, e métodos para a sua produção | |
DE69433523D1 (de) | Makromolekulare Mikropartikel und Verfahren zur ihrer Herstellung | |
BRPI0507294B8 (pt) | processo de fabricação de um gel reticulado biocompatível, gel, e, utilização do gel | |
ES2183782T3 (es) | Material de sutura para heridas a base de metilideno malonato. | |
ES2396972T3 (es) | Productos para el cuidado de heridas con contenido de queretina | |
BR0113087A (pt) | Novas composições de minoxidil | |
BRPI0802749A2 (pt) | composição cosmética, uso de uma composição e processo cosmético de tratamento das matérias queratìnicas | |
CN106146865A (zh) | 一种双网络高强度丝蛋白水凝胶及其制备方法 | |
EE03004B1 (et) | Tselluloosi sisaldava teraviljaekstrakti valmistamise meetod | |
AR005873A1 (es) | Composicion de latex modificado que tiene una velocidad de secado perfeccionada, composicion de revestimiento entrecruzable que la contiene,composicion de revestimiento curable por radiacion que la contiene, metodo para proporcionar un revestimiento protector entrecruzado en un substrato y | |
ES2159090T3 (es) | Composicion cosmetica para espuma capilar. | |
ATE269113T1 (de) | Sprühfähige wundversorgungszusammensetzung | |
EP0999236A4 (en) | HARDENABLE COMPOSITION | |
ATE235213T1 (de) | Haarformungszusammensetzungen von silikonfreien und silikongepfropften polymeren mit einem niedrigen gehalt an flüchtigem kohlenwasserstoffhaltigem lösungsmittel | |
Qi et al. | Preparation of a Salecan/poly (2‐acrylamido‐2‐methylpropanosulfonic acid‐co‐[2‐(methacryloxy) ethyl] trimethylammonium chloride) Semi‐IPN Hydrogel for Drug Delivery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] |
Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI. |
|
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B11D | Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time | ||
B15K | Others concerning applications: alteration of classification |
Ipc: C08L 71/02 (2006.01), A61K 47/60 (2017.01), A61K 4 |